Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.
about
CD133 antigen expression in ovarian cancer53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancersIn vitro comparative models for canine and human breast cancersHomologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian CancerEpithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistancePancreatic cancer stem cells: emerging target for designing novel therapyTargeting CSC-related miRNAs for cancer therapy by natural agentsFine tuning chemotherapy to match BRCA1 statusTumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerRegulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signalingDrug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanismsA phenotypic mouse model of basaloid breast tumorsTargeting tumour-initiating cells with TRAIL based combination therapy ensures complete and lasting eradication of multiple myeloma tumours in vivoDrug screening identifies niclosamide as an inhibitor of breast cancer stem-like cellsStress granule-associated protein G3BP2 regulates breast tumor initiation.Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells.Cancer stem cells: a systems biology view of their role in prognosis and therapySimvastatin induces derepression of PTEN expression via NFkappaB to inhibit breast cancer cell growth.Microenvironment, oncoantigens, and antitumor vaccination: lessons learned from BALB-neuT mice.Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasisBiomarkers to Target Heterogeneous Breast Cancer Stem CellsSulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cellsArsenic-specific stem cell selection during malignant transformation.Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells.D-K6L 9 peptide combination with IL-12 inhibits the recurrence of tumors in mice.Pancreatic cancer stem cells and EMT in drug resistance and metastasis.The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancerThe dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.Synergistic therapeutic effect of cisplatin and phosphatidylinositol 3-kinase (PI3K) inhibitors in cancer growth and metastasis of Brca1 mutant tumors.Oncogenes and tumor suppressor genesAntitumor Agents. 282. 2'-(R)-O-acetylglaucarubinone, a quassinoid from Odyendyea gabonensis as a potential anti-breast and anti-ovarian cancer agent.Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancerTargeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.Tumor-initiating function of nucleostemin-enriched mammary tumor cells.Antitumor agents 279. Structure-activity relationship and in vivo studies of novel 2-(furan-2-yl)naphthalen-1-ol (FNO) analogs as potent and selective anti-breast cancer agents.Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells.The TBC1D15 oncoprotein controls stem cell self-renewal through destabilization of the Numb-p53 complexTumor-initiating cells are not enriched in cisplatin-surviving BRCA1;p53-deficient mammary tumor cells in vivo.An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cellsRoles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.
P2860
Q21093306-B4B46E8C-D700-4D39-B32C-266DC50462EDQ24600350-04371709-FB29-47CC-B760-565AE8F2B3A5Q26752714-E96D97D5-EFC5-4C7B-BB86-E36BD886DE31Q26783551-D5FB98AB-FB4D-4DDD-805C-B57CF4284F2DQ26824386-88330FF8-EB73-4B93-A812-3E55C76E49FBQ26863365-B5A55DDB-1C55-43B0-AD0F-3D97FB2354A0Q27003230-76E882A5-D344-4DB2-A3BD-F8277DCA6621Q27694529-4B33F85B-EFFC-4AAB-9551-CAA98BA3AAE1Q28396304-079439F3-F8E3-4897-96D4-6548A9373A07Q28475546-C1F15E9A-3F46-4447-97C7-AD0FE6487D77Q28477091-15A2461B-7C69-4640-9C14-0DDF82D914CCQ28480588-C8CB4EE2-204B-4C09-B7A1-331E51E713CCQ28483760-C7B186EA-7778-4067-9097-8FFE0107C893Q28533608-4329C6C0-DE28-4742-98CD-B14D67B19328Q30008789-CE5EF32E-529F-4618-8B12-97657D4995AEQ30353532-A7DF245C-26E1-4CFC-83E6-50C7716908D8Q33569712-2684EEBD-2929-4531-B807-93C79F1236AFQ33678607-6ACE266E-373D-4A59-91BF-D3A1DEAEAF1BQ33786788-E756965B-362E-4FC6-B38C-AAC3B9AE0DBBQ33789414-04764743-9358-43D9-8D35-56E1C965AD26Q33811149-193A7E81-E080-48AE-8686-CA33BD7841E6Q33820656-480C56F9-ABD4-4A46-97AC-DA6B905DE7F2Q33828693-7629588A-48E7-4317-92C1-DB629CF4540AQ33842071-AEFB6519-8AF1-4AAD-B6E3-A4EDF534A7CBQ33883123-BFD9DFE8-7713-4EBC-AEFD-409E4D28AA6BQ33886120-CEE77D0E-5D63-44E1-B8D6-B9C34A8C7EAAQ34102670-6228E1D8-AAE3-4E6F-A5C8-87A1E857BA88Q34105402-0A604345-5E89-48BF-A4C4-1C18F937BE66Q34107207-ECBE3915-EDCB-4FC9-9038-BA0F307CCCCBQ34149922-98BFE869-2E4E-4AE1-AD83-E8BD1CDA9154Q34196547-ABFAA130-99B3-4D21-BEC0-CDE923F4C881Q34203675-038A6961-895C-414A-84E0-8049D6D8C893Q34208986-FA94888E-1D78-468D-8DE7-77A0FFFAA7AFQ34316303-AEB615BE-C827-43F1-8D69-663F6ACE834EQ34446759-D423E25F-9067-49B3-B625-964FAAE60B13Q34574786-351F4CF3-2168-41A8-9A5A-94F90BA2811FQ34612004-1988EC2D-283C-4FCF-934A-56C882F21D93Q34619763-5112B811-E142-4E76-931A-53F6AF987E14Q34765600-C7EDA29E-C96B-43F4-982A-03031DCB6E32Q34966603-4DFE2EC7-D309-413D-9283-A948E91A8A46
P2860
Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cancer stem cells contribute t ...... mediated mouse mammary tumors.
@en
type
label
Cancer stem cells contribute t ...... mediated mouse mammary tumors.
@en
prefLabel
Cancer stem cells contribute t ...... mediated mouse mammary tumors.
@en
P2093
P2860
P1433
P1476
Cancer stem cells contribute t ...... -mediated mouse mammary tumors
@en
P2093
Christopher R Smith
Eric J Stanbridge
Eva Y-H P Lee
Gabriel N Hortobagyi
Gordon B Mills
Norazizah Shafee
P2860
P304
P356
10.1158/0008-5472.CAN-07-5480
P407
P577
2008-05-01T00:00:00Z